Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John Xu
Efficacy and Safety of Metreleptin in Patients With Partial Lipodystrophy: Lessons From an Expanded Access Program
Journal of Diabetes & Metabolism
Related publications
The Maraviroc Expanded Access Program — Safety and Efficacy Data From an Open-Label Study
HIV Clinical Trials
Psy11 - Real-World Experience of Generalized Lipodystrophy Patients Enrolled in the Metreleptin Early Access Program: Initial Results
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Effects of Long-Term Metreleptin Treatment in Patients With Lipodystrophy
Endocrine Practice
Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Defibrotide in a Subset Analysis of Late-Onset Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) Patients From an Ongoing, Expanded-Access Program
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Metreleptin in Lipodystrophy: A Profile of Its Use
Drugs and Therapy Perspectives
Pharmacology
EFFECTS: An Expanded Access Program of Everolimus for Patients With Subependymal Giant Cell Astrocytoma Associated With Tuberous Sclerosis Complex
BMC Neurology
Medicine
Neurology
Metreleptin-Mediated Improvements in Insulin Sensitivity Are Independent of Food Intake in Humans With Lipodystrophy
Journal of Clinical Investigation
Medicine
1302pdifct-1502 CLINIVO: Real-Life Experience With Nivolumab in 600 Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC): Efficacy and Safety of Nivolumab and Post-Nivolumab Treatment in the French Expanded Access Program (EAP)
Annals of Oncology
Medicine
Oncology
Hematology
Acquired Partial Lipodystrophy
